drugset / Trial / NCT02558439

Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain

NCT02558439

Phase 2 Completed 175 enrolled Centrexion Therapeutics
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of a single injection of CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.

Timeline

Start
2015-08
Primary completion
2016-10
Completion
2017-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.5 mg Other
Subject Capsaicin Small molecule 1 mg Other

Indications